Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-24

Clinical Trial Update: Morphine, Dyspnea, Exercise and COPD [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating morphine for dyspnea in chronic obstructive pulmonary disease during exercise, with the study status c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: UNKNOWN